Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc [More Details]
Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review (Abstract)
Low-Dose Naltrexone for Chronic Pain: Update and Systemic Review
Curr Pain Headache Rep
26 Aug 2020
Purpose of review: The purpose of this review is to evaluate and explain our current understanding of the clinical use of low-dose naltrexone in the treatment of chronic pain.
Recent findings: Recent pre-clinical uses and clinical studies further elucidate the use of low-dose naltrexone in the treatment of chronic pain. Low-dose naltrexone (LDN) has shown promise to reduce symptoms related to chronic pain conditions such as fibromyalgia, inflammatory bowel conditions, and multiple sclerosis. The mechanism of LDN appears to be modulation of neuro-inflammation, specifically, the modulation of the glial cells and release of inflammatory chemicals in the central nervous system. These effects appear to unique at low dosage compared to dosage for food and drug administration approved use for alcohol and opioid dependence. We review the evidence that LDN has shown more than promise and should be further investigated in clinical practice.
Keywords: Chronic pain; Fibromyalgia; Naltrexone; Neuroinflammation.